Tempus, USC Partner to Accelerate AI-Driven Precision Medicine

Tempus AI Inc. and the Keck School of Medicine of USC and Keck Medicine of USC have forged a multi-faceted collaboration to transform patient care and accelerate research through data and artificial intelligence (AI).

The partnership aims to transform care delivery across more than 1.5 million annual patient visits to the USC Norris Comprehensive Cancer Center, the Keck Hospital of USC, USC Verdugo Hills and all USC-affiliated hospitals and clinics across Southern California.

“By working closely with Tempus, and in collaboration with clinical, research, and operational leaders across USC, we are aligning research, clinical care, and innovation priorities that put the patient first,” said Vasiliki Anest, Ph.D., chief innovation officer at the Keck School of Medicine of USC. “Our patient-focused commitment is to ensure discoveries and clinical innovations move thoughtfully and responsibly into practice, expanding access to personalized care and clinical trials, supporting physicians, and improving patient outcomes.”

The collaboration is built on four foundational pillars, co-created to drive clinical impact, research scale, and long-term innovation. These include clinical testing, which enables personalized medicine by integrating Tempus’ advanced molecular diagnostics and comprehensive genomic profiling into Keck Medicine’s clinical workflows; clinical trial matching, which automates the identification of eligible patients for targeted therapies and clinical trials through Tempus’ TIME Trial Program; clinical care gap pathways, which use AI-driven insights to identify and close gaps in patient care; and research collaboration and co-development, which accelerates the translation of academic insights into validated diagnostics and therapies while jointly developing AI tools that connect research discoveries to clinical care.

“We are excited to embark on this collaboration with USC, an institution that shares our commitment to advancing healthcare through data and technology,” Tempus Chief Medical Officer of Oncology Ezra Cohen, M.D., “By bringing together Tempus’ AI-powered platform with USC’s research and clinical expertise, we have the opportunity to create a powerful, integrated ecosystem that meaningfully transforms care delivery.”

Tempus is a technology company advancing precision medicine through the practical application of AI in healthcare. With one of the world’s largest libraries of multimodal data and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development, and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.